You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The closing range uses available history since Sep 18, 2026; less than a full year is stored.
Electra Therapeutics, Inc. closed its IPO, selling 23,333,334 common shares at $15.00 per share for approximately $350.0 million in gross proceeds. It filed an amended and restated certificate of incorporation and adopted amended and restated bylaws effective September 21, 2026.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ETRA
this stock
Electra Therapeutics, Inc.
|
$461.34M | — | — | — | 0.7% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$138.71B | +20.7% | +46.2% | 35.2 | 1.7% |
|
MRNA
Moderna, Inc.
|
$96.40B | +762.0% | +4.3% | — | 8.2% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$93.82B | +17.2% | +20.8% | 20.1 | 2.1% |
|
CSLLY
Csl Ltd
|
$67.11B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Electra Therapeutics, Inc. closed its IPO, selling 23,333,334 common shares at $15.00 per share for approximately $350.0 million in gross proceeds. It filed an amended and restated certificate of incorporation and adopted amended and restated bylaws effective September 21, 2026.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ETRA | -3.7% | -13.7% | — | -3.7% | — |
| SPY | -2.7% | -5.6% | -0.5% | -2.7% | +7.8% |
| vs SPY | -1.0% | -8.2% | — | -1.0% | — |
